Richard A. Paulson insider trades

Open-market stock purchases and sales by Richard A. Paulson, President and CEO at Karyopharm Therapeutics Inc, from SEC Form 4 filings since Mar 5, 2020.

Recent trades

DateStockTradeValue
May 14, 2026KPTI Karyopharm Therapeutics IncSold$20.9K
May 13, 2026KPTI Karyopharm Therapeutics IncBought (not open market)—
Mar 2, 2026KPTI Karyopharm Therapeutics IncSold$116K
Feb 5, 2026KPTI Karyopharm Therapeutics IncBought (not open market)—

Companies traded

  • KPTI Karyopharm Therapeutics Inc: 46 sales, last May 14, 2026
  • BLUE bluebird bio, Inc: other filings, last Jun 2, 2025

Get free alerts when Richard A. Paulson files a new trade →